相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Partial cooperative unfolding in proteins as observed by hydrogen exchange mass spectrometry
John R. Engen et al.
INTERNATIONAL REVIEWS IN PHYSICAL CHEMISTRY (2013)
Enhanced SH3/Linker Interaction Overcomes Abl Kinase Activation by Gatekeeper and Myristic Acid Binding Pocket Mutations and Increases Sensitivity to Small Molecule Inhibitors
Shoghag Panjarian et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Targeting the SH2-Kinase Interface in Bcr-Abl Inhibits Leukemogenesis
Florian Grebien et al.
CELL (2011)
Discovery and Characterization of a Cell-Permeable, Small-Molecule c-Abl Kinase Activator that Binds to the Myristoyl Binding Site
Jingsong Yang et al.
CHEMISTRY & BIOLOGY (2011)
CDK1-mediated Phosphorylation of Abi1 Attenuates Bcr-Abl-induced F-actin Assembly and Tyrosine Phosphorylation of WAVE Complex during Mitosis
Chunmei Zhuang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Allosteric Interactions between the Myristate- and ATP-Site of the Abl Kinase
Roxana E. Iacob et al.
PLOS ONE (2011)
Hydrogen exchange mass spectrometry: what is it and what can it tell us?
Sean R. Marcsisin et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2010)
Expression of a Src Family Kinase in Chronic Myelogenous Leukemia Cells Induces Resistance to Imatinib in a Kinase-dependent Manner
Teodora Pene-Dumitrescu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Targeting Bcr-Abl by combining allosteric with ATP-binding-site inhibitors
Jianming Zhang et al.
NATURE (2010)
Multidomain assembled states of Hck tyrosine kinase in solution
Sichun Yang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Determination of amide hydrogen exchange by mass spectrometry: A new tool for protein structure elucidation
Zhongqi Zhang et al.
PROTEIN SCIENCE (2010)
ABL Tyrosine Kinases: Evolution of Function, Regulation, and Specificity
John Colicelli
SCIENCE SIGNALING (2010)
Analysis of Protein Conformation and Dynamics by Hydrogen/Deuterium Exchange MS
John R. Engen
ANALYTICAL CHEMISTRY (2009)
Equally Potent Inhibition of c-Src and Abl by Compounds that Recognize Inactive Kinase Conformations
Markus A. Seeliger et al.
CANCER RESEARCH (2009)
A conserved protonation-dependent switch controls drug binding in the Abl kinase
Yibing Shan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Conformational disturbance in Abl kinase upon mutation and deregulation
Roxana E. Iacob et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Hierarchical Modeling of Activation Mechanisms in the ABL and EGFR Kinase Domains: Thermodynamic and Mechanistic Catalysts of Kinase Activation by Cancer Mutations
Anshuman Dixit et al.
PLOS COMPUTATIONAL BIOLOGY (2009)
Ab1 N-terminal Cap stabilization of SH3 domain dynamics
Shugui Chen et al.
BIOCHEMISTRY (2008)
Allosteric inhibition of the nonMyristoylated c-Abl tyrosine kinase by phosphopeptides derived from Abi1/Hssh3bp1
Xiaoling Xiong et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2008)
Structural coupling of SH2-kinase domains links fes and Abl substrate recognition and kinase activation
Panagis Filippakopoulos et al.
CELL (2008)
Structure and dynamic regulation of Src-family kinases
J. R. Engen et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2008)
Enhancement of ABL Kinase Catalytic Efficiency by a Direct Binding Regulator Is Independent of Other Regulatory Mechanisms
Xiaoqing Cao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Tyrosine Phosphorylation in the SH3 Domain Disrupts Negative Regulatory Interactions within the c-Abl Kinase Core
Shugui Chen et al.
JOURNAL OF MOLECULAR BIOLOGY (2008)
Activation of tyrosine kinases by mutation of the gatekeeper threonine
Mohammad Azam et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2008)
MT1-MMP as a downstream target of BCR-ABL/ABL interactor 1 signaling: polarized distribution and involvement in BCR-ABL-stimulated leukemic cell migration
X. Sun et al.
LEUKEMIA (2008)
Oncogenic activation of c-Abl in non-small cell lung cancer cells lacking FUS1 expression: inhibition of c-Abl by the tumor suppressor gene product Fus1
J. Lin et al.
ONCOGENE (2007)
Bcr-Abl induces abnormal cytoskeleton remodeling, β1 integrin clustering and increased cell adhesion to fibronectin through the Abl interactor 1 pathway
Yingzhu Li et al.
JOURNAL OF CELL SCIENCE (2007)
The Ab1 SH2-kinase linker naturally adopts a conformation competent for SH3 domain binding
Shugui Chen et al.
PROTEIN SCIENCE (2007)
c-Src binds to the cancer drug imatinib with an inactive Abl/c-Kit conformation and a distributed thermodynamic penalty
Markus A. Seeliger et al.
STRUCTURE (2007)
Src family kinases phosphorylate the Bcr-Abl SH3-SH2 region and modulate Bcr-Abl transforming activity
Malcolm A. Meyn et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
The structure of dasatinib (BMS-354825) bound to activated ABL kinase domain elucidates its inhibitory activity against imatinib-resistant ABL mutants
John S. Tokarski et al.
CANCER RESEARCH (2006)
A Src-like inactive conformation in the Abl tyrosine kinase domain
Nicholas M. Levinson et al.
PLOS BIOLOGY (2006)
Partial unfolding of diverse SH3 domains on a wide timescale
TE Wales et al.
JOURNAL OF MOLECULAR BIOLOGY (2006)
Organization of the SH3-SH2 unit in active and inactive forms of the c-Abl tyrosine kinase
B Nagar et al.
MOLECULAR CELL (2006)
Allosteric inhibitors of Bcr-abl-dependent cell proliferation
FJ Adrián et al.
NATURE CHEMICAL BIOLOGY (2006)
Hydrogen exchange mass spectrometry for the analysis of protein dynamics
TE Wales et al.
MASS SPECTROMETRY REVIEWS (2006)
An examination of dynamics crosstalk between SH2 and SH3 domains by hydrogen/deuterium exchange and mass spectrometry
JM Hochrein et al.
PROTEIN SCIENCE (2006)
Activation of the Src family kinase Hck without SH3-linker release
EC Lerner et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Regulation of the C-Abl and Bcr-Abl tyrosine kinases
O Hantschel et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2004)
A myristoyl/phosphotyrosine switch regulates c-Abl
O Hantschel et al.
CELL (2003)
Structural basis for the autoinhibition of c-Abl tyrosine kinase
B Nagar et al.
CELL (2003)
BCR-ABL independence and LYN kinase overexpression in chronic myelogenous leukemia cells selected for resistance to STI571
NJ Donato et al.
BLOOD (2003)
Multiple BCR-ABL kinase domain mutations confer polyclonal resistance to the tyrosine kinase inhibitor imatinib (STI571) in chronic phase and blast crisis chronic myeloid leukemia
NP Shah et al.
CANCER CELL (2002)
The conformational plasticity of protein kinases
M Huse et al.
CELL (2002)
Phosphorylation and structure-based functional studies reveal a positive and a negative role for the activation loop of the c-Abl tyrosine kinase
K Dorey et al.
ONCOGENE (2001)
Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification
ME Gorre et al.
SCIENCE (2001)
Activation of c-Abl kinase activity and transformation by a chemical inducer of dimerization
KM Smith et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
c-Ab1 has high intrinsic tyrosine kinase activity that is stimulated by mutation of the Src homology 3 domain and by autophosphorylation at two distinct regulatory tyrosines
BB Brasher et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Structural mechanism for STI-571 inhibition of Abelson tyrosine kinase
T Schindler et al.
SCIENCE (2000)
Interaction of the N-methyl-D-aspartic acid receptor NR2D subunit with the c-Abl tyrosine kinase
RT Glover et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
